Tessera Therapeutics

Jacob Rubens was supposed to be paying attention in his chemistry lecture. Instead, flipping through Rolling Stone, he stumbled upon an interview that would alter the trajectory of his life. “I was re

Venture capital mega-rounds of $100m or more have surged in 2024 and the trend has continued in December, with announcements on 19 December that Ottimo Pharma’s series A round brought in more than $14

Flagship Pioneering has more than doubled the funding it has raised since 2021 and will direct it toward building more than a dozen companies across human health, artificial intelligence and sustainab

SXSW is known for attracting celebrities from the worlds of film, music and tech, and this year drew a unique combination of medical, regulatory and entrepreneurial medtech expertise in the person of